# Oral Dosage Form New Animal Drugs; Selegiline Hydrochloride Tablets
> **Food and Drug Administration** · Final rule. · Published 1999-01-13 · Effective 1999-01-13 · 64 FR 2121
## Document
- **Document number:** 99-739
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 64 FR 2121
- **CFR reference:** 21 CFR 520
- **Publication date:** 1999-01-13
- **Effective date:** 1999-01-13
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. The supplemental NADA provides for oral veterinary prescription use of selegiline hydrochloride tablets for dogs for the control of clinical signs associated with cognitive dysfunction syndrome.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1999/01/13/99-739/oral-dosage-form-new-animal-drugs-selegiline-hydrochloride-tablets)
---
*AI Analytics · CC0 1.0*